Silencing TUG1 inhibits tumor growth and metastasis, enhances the infiltration of CD8+ T cells and M1 macrophages, and activates CD8+ T cells through PD-L1 while promoting macrophage phagocytosis via CD47. Here, CD274 is linked to neoplasm.